Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.73 -0.05 (-0.20%)
Official Closing Price Updated: 7:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Gold Poised for Record Highs Above US$3,860 as U.S. Government Shutdown Looms, Igniting Safe-Haven Rush
As the U.S. government shutdown deadline looms on September 30, 2025, financial markets are bracing for impact, with gold prices exhibiting strong upward momentum, driven by intense safe-haven demand.... 
Via MarketMinute
Topics Bonds Economy
Global Markets Defy Headwinds: Resilient Sentiment Prevails Despite Shutdown Fears
As the third quarter of 2025 drew to a close on September 30, global financial markets demonstrated a remarkable display of resilience, largely shrugging off significant geopolitical uncertainties and... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Trump Announces Pfizer Drug-Pricing Deal, Company To Invest $70 Billion in US Manufacturing
Via Stocktwits
Topics Government
U.S. Drug Pricing Reforms Send Ripples Across Global Healthcare Sector
The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Global Markets Brace for US Government Shutdown: A Deep Dive into Investor Jitters and Currency Swings
As September 2025 draws to a close, a palpable sense of unease has settled over global financial markets, triggered by the looming specter of a U.S. government shutdown. While Wall Street indices... 
Via MarketMinute
Topics Economy Stocks World Trade
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
CoreWeave's Sudden Plunge: A Reality Check for the High-Flying AI Infrastructure Market
Today's market close saw an unexpected and significant downturn for CoreWeave (NASDAQ: CRWV), the specialized AI cloud provider, marking it as one of the day's bottom performers. This abrupt reversal... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
Pfizer Plummets as Key Obesity Drug Candidate Faces Major Setback, Shaking Investor Confidence
New York, NY – September 30, 2025 – Shares of pharmaceutical giant Pfizer (NYSE: PFE) experienced a dramatic decline today, making it one of the market's bottom performers, following an unexpected and... 
Via MarketMinute
Topics Intellectual Property
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a... 
Via MarketMinute
Topics Government
Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing... 
Via MarketMinute
Topics Economy Government World Trade
Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility
As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move... 
Via MarketMinute
Topics Economy Government Supply Chain
AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
Why Are Eli Lilly (LLY) Shares Soaring Today
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 5.5% in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the... 
Via StockStory
Topics Government
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is... 
Via StockStory
Topics Government World Trade
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
Bio-Techne (TECH) Shares Skyrocket, What You Need To Know
Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 5.3% in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical... 
Via StockStory
Topics Government
What's going on in today's session: S&P500 movers
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Why Pfizer (PFE) Stock Is Trading Up Today
Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 5.9% in the afternoon session after the company reached an agreement with the U.S. government to lower drug prices and reported positive... 
Via StockStory
Topics Death
‘TrumpRx’ Deal With Pfizer To Offer Discount Drugs Direct To Consumers
TrumpRx would allow people to buy drugs directly from a government website, at a discounted price negotiated by the government. 
Via Talk Markets
Pfizer Becomes First Drugmaker To Join Trump's Price Cut Push
Pfizer and the Trump Administration have reached a landmark agreement to lower U.S. prescription drug prices. 
Via Benzinga
Topics Government
Curious about the most active S&P500 stocks in today's session?
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
Via Chartmill
Unusual volume S&P500 stocks in Tuesday's session
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. 
Via Chartmill
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
From Pfizer Inc.
Via Business Wire
Discover which S&P500 stocks are making waves on Tuesday.
Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Pfizer Shares Gain Amid Reports Of Deal With The US Government
Pfizer stock climbed over 3% on news of an impending drug-pricing deal with the Trump administration. 
Via Talk Markets
Topics Government
Why Pfizer Stock Just Popped
Bowing to pressure from Washington, the company is preparing to announce price cuts on drugs for U.S. customers. 
Via The Motley Fool
Topics Government
Pfizer Shares Are Trading Higher Tuesday: What's Going On?
Pfizer, Inc. (NYSE:PFE) shares are trading higher on Tuesday after The Washington Post reported that President Donald Trump will announce a drug-pricing deal with the company. 
Via Benzinga
Topics Government
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.